Supply Chain
Long wait times, crowded waiting rooms, and frustrated staff are often symptoms of inefficient workflows driven by physical space constraints.…
Two drug industry executives predict President Donald Trump will roll out proposals to tackle high drug costs within the next few weeks to months, reports Bloomberg.
HHS's Office of Inspector General estimates Mylan may have overcharged Medicaid $1.27 billion for EpiPens over the last decade by improperly classifying the devices as generic products under CMS' rebate program, reports STAT.
A nationwide sodium bicarbonate shortage piqued the interest of readers last month.
When a patient requires a medication adjustment to better manage high blood pressure, switching to a fixed-dose combination therapy is the most cost effective option, according to a study published in the Journal of Managed Care & Specialty Pharmacy.
University of Pittsburgh (Pa.) developed a seed capital fund to encourage the development of medications, reports the Pittsburgh Post-Gazette.
The Food and Drug Administration on Tuesday approved four drugmakers' generic versions of Strattera — Eli Lilly's attention-deficit/hyperactivity disorder drug.
Despite some progress, the supply chain industry is still a very "white male profession," according to Lora Cecere, founder and CEO of the research firm Supply Chain Insights.
High prescription drug list prices may increase out-of-pocket costs for Medicare beneficiaries, according to an article published in JAMA Internal Medicine.
Mallinckrodt Pharmaceuticals is looking to divest its generic drug business, unnamed sources told Reuters.
The Food and Drug Administration on Friday rejected Sunovion Pharmaceuticals' treatment for chronic obstructive pulmonary disease.